Molecular Characterization Trial
分子表征试验
基本信息
- 批准号:10712292
- 负责人:
- 金额:$ 32.51万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-09-19 至 2028-08-31
- 项目状态:未结题
- 来源:
- 关键词:AccelerationAdultAftercareAmendmentAppearanceArtificial IntelligenceAutopsyBiological AssayBiopsyBloodBlood specimenCaliforniaCancer BiologyCancer CenterCaregiversCharacteristicsChildChildhoodClinicalClinical DataClinical ResearchClinical TrialsCollaborationsCollectionCommunitiesConsentDataData CollectionData ElementData ScienceData Storage and RetrievalEnsureGoalsHandHealth protectionHeterogeneityImageInstitutionInvestigationKnowledgeLate EffectsLeadLong-Term SurvivorsMalignant Childhood NeoplasmMalignant NeoplasmsMolecularMutationNational Clinical Trials NetworkNeuroblastomaOncologyOperative Surgical ProceduresParentsPatientsPediatric Oncology GroupPerformancePilot ProjectsProceduresProtocols documentationRadiationRadiation OncologyRadiation exposureRadiation therapyRadiopharmaceuticalsRecurrenceReproducibilityResearchResearch Project GrantsResource SharingResourcesSamplingSan FranciscoSignal TransductionSiteSolid NeoplasmSourceStandardizationTestingThe Cancer Genome AtlasTherapeutic TrialsTissuesUniversitiesWorkage groupbiobankclinical trial protocolcohortdata resourcedesigndiffuse midline gliomadosimetryembryo tissuehigh riskimmune-related adverse eventsinnovationmetaiodobenzylguanidinemultidimensional datamultimodalityneoplastic cellneuro-oncologynovelpediatric patientsprogramsradiation responserisk minimizationsample collectionstandard of carestructured datasuccesstumorvalidation studies
项目摘要
PROJECT SUMMARY
The Molecular Characterization Trial (MCT) is the source of biospecimen and data resources for the ROBIN
Center. As such, its success is paramount to the success of the entire initiative, and strategies that expedite
the acquisition of these essential resources will accelerate the timeframe in which they are made available for
all the innovative work performed in the Research Projects and Cores. The Harvard/UCSF ROBIN has chosen
for its theme the study of pediatric malignancies as the optimal setting for in depth investigation into the impact
of heterogeneity, in both its tumor cell intrinsic and extrinsic manifestations, on radiation responses. The MCT
will achieve these goals via the following Aims: Aim 1: Coordinate the collection of biospecimens and
clinical data from cooperative group studies for use in ROBIN studies. The MCT will leverage two ongoing
trials: Pacific Pediatric Neuro-Oncology Consortium PNOC023 for diffuse midline glioma (DMG), and
Children’s Oncology Group (COG) ANBL1531 for neuroblastoma (NBL). The study chairs for each trial are co-
leads of the MCT and Project 2, respectively. As a novel feature of the MCT, matched pairs of tumor samples
will be available from subjects who underwent pre-treatment biopsies and subsequently had post-treatment
surgical (NBL) or post-mortem (DMG) tissues obtained via established protocols. The ROBIN investigators will
also leverage additional resources that are uniquely available to them, including a collection of thirty DMG
tumor samples that are distinct from those obtained on the PNOC023 study and already in hand. The MCT will
also bolster an aim on late effects by obtaining blood samples and clinical data from the COG Late Effects after
High-Risk Neuroblastoma (LEAHRN) study, which includes 24 long-term survivors previously treated with the
radiopharmaceutical 131I-MIBG. Aim 2: Manage the regulatory aspects of the MCT, including site protocols
for collection of protected health information (PHI) and biospecimens in institutional biorepositories. Clinical
research and data coordinators will work with site leads at both Dana-Farber/Harvard Cancer Center and
UCSF to ensure rigorous and timely submission of study protocols, amendments, and continuing reviews so
that the work can steadfastly proceed. Also, because all PHI will flow through the MCT, which provides de-
identified resources to other ROBIN components, this will minimize risks to subject confidentiality. Aim 3:
Maintain standard operating procedures for processing and analyzing tumor, blood and CSF samples and
storing incoming and resultant high-dimensional data. Given the vast amounts of data involved, and the
intricate assays being performed, it is essential that the work is performed in a harmonized way to maintain
rigor and reproducibility. The MCT will rely on the combined expertise within the Clinical Artificial Intelligence
and Imaging Core and the Molecular Data Science and Advanced Dosimetry Core to ensure compliance
with de-identification and data storage standards so that the rich resources generated by the ROBIN can be
used effectively by the broader research community in pilot projects and beyond.
项目总结
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
David Kozono其他文献
David Kozono的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('David Kozono', 18)}}的其他基金
Characterization of lung cancer radiosensitizers from genome-wide RNAi screens
全基因组 RNAi 筛选中肺癌放射增敏剂的表征
- 批准号:
8880151 - 财政年份:2013
- 资助金额:
$ 32.51万 - 项目类别:
Characterization of lung cancer radiosensitizers from genome-wide RNAi screens
全基因组 RNAi 筛选中肺癌放射增敏剂的表征
- 批准号:
8692687 - 财政年份:2013
- 资助金额:
$ 32.51万 - 项目类别:
Characterization of lung cancer radiosensitizers from genome-wide RNAi screens
全基因组 RNAi 筛选中肺癌放射增敏剂的表征
- 批准号:
8581441 - 财政年份:2013
- 资助金额:
$ 32.51万 - 项目类别:
相似海外基金
Co-designing a lifestyle, stop-vaping intervention for ex-smoking, adult vapers (CLOVER study)
为戒烟的成年电子烟使用者共同设计生活方式、戒烟干预措施(CLOVER 研究)
- 批准号:
MR/Z503605/1 - 财政年份:2024
- 资助金额:
$ 32.51万 - 项目类别:
Research Grant
Early Life Antecedents Predicting Adult Daily Affective Reactivity to Stress
早期生活经历预测成人对压力的日常情感反应
- 批准号:
2336167 - 财政年份:2024
- 资助金额:
$ 32.51万 - 项目类别:
Standard Grant
RAPID: Affective Mechanisms of Adjustment in Diverse Emerging Adult Student Communities Before, During, and Beyond the COVID-19 Pandemic
RAPID:COVID-19 大流行之前、期间和之后不同新兴成人学生社区的情感调整机制
- 批准号:
2402691 - 财政年份:2024
- 资助金额:
$ 32.51万 - 项目类别:
Standard Grant
Elucidation of Adult Newt Cells Regulating the ZRS enhancer during Limb Regeneration
阐明成体蝾螈细胞在肢体再生过程中调节 ZRS 增强子
- 批准号:
24K12150 - 财政年份:2024
- 资助金额:
$ 32.51万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Migrant Youth and the Sociolegal Construction of Child and Adult Categories
流动青年与儿童和成人类别的社会法律建构
- 批准号:
2341428 - 财政年份:2024
- 资助金额:
$ 32.51万 - 项目类别:
Standard Grant
Understanding how platelets mediate new neuron formation in the adult brain
了解血小板如何介导成人大脑中新神经元的形成
- 批准号:
DE240100561 - 财政年份:2024
- 资助金额:
$ 32.51万 - 项目类别:
Discovery Early Career Researcher Award
Laboratory testing and development of a new adult ankle splint
新型成人踝关节夹板的实验室测试和开发
- 批准号:
10065645 - 财政年份:2023
- 资助金额:
$ 32.51万 - 项目类别:
Collaborative R&D
Usefulness of a question prompt sheet for onco-fertility in adolescent and young adult patients under 25 years old.
问题提示表对于 25 岁以下青少年和年轻成年患者的肿瘤生育力的有用性。
- 批准号:
23K09542 - 财政年份:2023
- 资助金额:
$ 32.51万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Identification of new specific molecules associated with right ventricular dysfunction in adult patients with congenital heart disease
鉴定与成年先天性心脏病患者右心室功能障碍相关的新特异性分子
- 批准号:
23K07552 - 财政年份:2023
- 资助金额:
$ 32.51万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Issue identifications and model developments in transitional care for patients with adult congenital heart disease.
成人先天性心脏病患者过渡护理的问题识别和模型开发。
- 批准号:
23K07559 - 财政年份:2023
- 资助金额:
$ 32.51万 - 项目类别:
Grant-in-Aid for Scientific Research (C)